Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of an SNP in SCAP gene on lipid-lowering response to rosuvastatin in Indian patients with metabolic syndrome.

Pharmacogenomics - 1 Dec 2016

Rafeeq Misbahuddin M, Ahmad Farida, Rahman Syed Z, Siddiqi Sheelu S, Shakil Shazi

Abstract excerpt

AIM: Statins treat dyslipidemia associated with metabolic syndrome. Genetic factors contribute to variable response. Sterol regulatory element-binding factors cleavage-activating protein (SCAP) pathway regulates lipid homeostasis, so effect of SNP in SCAP gene on rosuvastatin response was studied. MATERIALS & METHODS: Metabolic syndrome patients with low-density lipoprotein-cholesterol ≥130 mg/dl, were prescribed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticholesteremic Agents
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Intracellular Signaling Peptides and Proteins

Share to Membrane Proteins

Share to Metabolic Syndrome

Share to Polymorphism, Single Nucleotide

Share to Rosuvastatin Calcium

Source

Identifiers

PMID: 27885915
DOI: 10.2217/pgs.16.30

Genes

SCAP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of an SNP in SCAP gene on lipid-lowering response to rosuvastatin in Indian patients with metabolic syndrome.PMID 27885915Read ↗

Effect of genetic polymorphisms in SREBF-SCAP pathway on therapeutic response to rosuvastatin in Saudi metabolic syndrome patients.Semantic proximity Read ↗

Correlation between SCAP Genetic Polymorphism and Coronary Artery Disease in a Han population in Xinjiang, ChinaSemantic proximity Read ↗

Determinants of variable response to simvastatin treatment: the role of common variants of SCAP, SREBF-1a and SREBF-2 genes.Semantic proximity Read ↗

SCAP gene polymorphisms decrease the risk of nonalcoholic fatty liver disease in females with metabolic syndrome.Semantic proximity Read ↗

Genetic variations in sterol regulatory element binding protein cleavage-activating protein (SCAP) are associated with blood pressure in overweight/obese Chinese children.Semantic proximity Read ↗

Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response.Semantic proximity Read ↗

The discrete and combined effect of SREBP-2 and SCAP isoforms in the control of plasma lipids among familial hypercholesterolaemia patients.Semantic proximity Read ↗

Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients.Semantic proximity Read ↗

Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.Semantic proximity Read ↗

Genetic contribution to lipid target achievement with statin therapy: a prospective study.Semantic proximity Read ↗

Pharmacogenomics of Rosuvastatin: A Glocal (Global+Local) African Perspective and Expert Review on a Statin Drug.Semantic proximity Read ↗

Functional promoter polymorphism in SREBP cleavage-activating protein (SCAP).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.